Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 2, 2004, Pages 679-687

  Roman, David L ^a   Saldaña, Shannon N ^a   Nichols, David E ^a   Carroll, F Ivy ^b   Barker, Eric L ^a  

^a PURDUE UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHENYLTROPANE DERIVATIVE; AMPHETAMINE DERIVATIVE; AROMATIC AMINO ACID; CARRIER PROTEIN; CHIMERIC PROTEIN; COCAINE DERIVATIVE; INSECT PROTEIN; MEMBRANE PROTEIN; PSYCHOSTIMULANT AGENT; SEROTONIN; SEROTONIN TRANSPORTER; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL LINE; CELL STRAIN; CELL STRAIN HEK 293; CHEMISTRY; CHIMERA; CONTROLLED STUDY; DROSOPHILA; ELECTRICITY; EMBRYO; GENETICS; HUMAN; HUMAN CELL; METABOLISM; MOLECULAR MODEL; MOLECULAR RECOGNITION; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SPECIES; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION;

AMPHETAMINES; ANIMALS; CARRIER PROTEINS; CELL LINE; DROSOPHILA; DROSOPHILA PROTEINS; HUMANS; INSECT PROTEINS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RECOMBINANT FUSION PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM;

EID: 1642538969     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.057836     Document Type: Article

References (40)

1. Adkins EM, Barker EL, and Blakely RD (2001) Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Mol Pharmacol 59:514-523.
2. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93.
3. Amara SG and Sonders MS (1998) Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51:87-96.
4. Barker EL and Blakely RD (1995) Norepinephrine and serotonin transporters, in Psychopharmacology: The Fourth Generation of Progress (Floyd E. Bloom and David J. Kupfer eds) pp 321-333, Raven Press, New York.
5. Barker EL, Moore KR, Rakhshan F, and Blakely RD (1999) Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci 19:4705-4717.
6. Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, and Blakely RD (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem 273:19459-19468.
7. Blakely RD, De Felice LJ, and Hartzell HC (1994) Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196:263-281.
8. Blough BE, Abraham P, Lewin AH, Kuhar MJ, Boja JW, and Carroll FI (1996) Synthesis and transporter binding properties of 3 beta-(4′-alkyl-, 4′-alkenyl- and 4′-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs. J Med Chem 39:4027-4035.
9. Blough BE, Keverline KI, Nie Z, Navarro H, Kuhar MJ, and Carroll FI (2002) Synthesis and transporter binding properties of 3beta-[4′ -(phenylalkyl, -phenylalkenyl and -phenylalkynyl)phenyl] tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter. J Med Chem 45:4029-4037.
10. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
11. Carroll FI, Gao YG, Rahman MA, Abraham P, Parham K, Lewin AH, Boja JW, and Kuhar MJ (1991) Synthesis, ligand binding, QSAR and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters. J Med Chem 34:2719-2725.
12. Carroll FI, Kotian P, Dehghani A, Gray JL, Kuzemko MA, Parham KA, Abraham P, Lewin AH, Boja JW, and Kuhar MJ (1995) Cocaine and 3 beta-(4′-substituted phenyl)tropane-2 beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J Med Chem 38:379-388.
13. Carroll FI, Mascarella SW, Kuzemko MA, Gao Y, Abraham P, Lewin AH, Boja JW, and Kuhar MJ (1994) Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 3 beta-(3′-substituted phenyl)-, 3 beta-(4′-substituted phenyl)- and 3 beta-(3′, 4′ -disubstituted phenyl)tropane-2 beta-carboxylic acid methyl esters. J Med Chem 37:2865-2873.
14. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
15. Corey JL, Quick MW, Davidson N, Lester HA, and Guastella J (1994) A cocaine-sensitive Drosophila serotonin transporter: cloning, expression and electrophysiological characterization. Proc Natl Acad Sci USA 91:1188-1192.
16. Cozzi NV, Sievert MK, Shulgin AT, Jacob P, III and Ruoho AE (1999) Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines, Eur J Pharmacol 381:63-69.
17. Demchyshyn LL, Pristupa ZB, Sugamori KS, Barker EL, Blakely RD, Wolfgang WJ, Forte MA, and Niznik HB (1994) Cloning, expression and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. Proc Natl Acad Sci USA 91:5158-5162.
18. Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, and Janowsky A (1999) Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther 289:877-885.
19. Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, and Madras BK (2001) Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates? Synapse 42:129-140.
20. Hoffman BJ, Mezey E, and Brownstein MJ (1991) Cloning of a serotonin transporter affected by antidepressants. Science (Wash DC) 254:579-580.
21. Holmquist CR, Keverline-Frantz KI, Abraham P, Boja JW, Kuhar MJ, and Carroll FI (1996) 3 alpha-(4′-Substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter. J Med Chem 39:4139-4141.
22. Jones SR, Joseph JD, Barak LS, Caron MG, and Wightman RM (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406-2414.
23. Kantor L, Hewlett GH, and Gnegy ME (1999) Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J Neurosci 19:3801-3808.
24. Li AH, Moro S, Forsyth N, Melman N, Ji XD, and Jacobson KA (1999) Synthesis, CoMFA analysis and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem 42:706-721.
25. Marona-Lewicka D, Rhee G-S, Sprague JE, and Nichols DE (1995) Psychostimulant-like effects of p-fluoroamphetamine in the rat. Eur J Pharmacol 287:105-113.
26. Neumeyer JL, Tamagnan G, Wang S, Gao Y, Milius RA, Kula NS, and Baldessarini RJ (1996) N-Substituted analogs of 2 beta-carbomethoxy-3 beta-(4′-iodophenyl) tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem 39:543-548.
27. Neumeyer JL, Wang S, Gao Y, Milius RA, Kula NS, Campbell A, Baldessarini RJ, Zea-Ponce Y, Baldwin RM, and Innis RB (1994) N-omega-Fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem 37:1558-1561.
28. Newman AH, Izenwasser S, Robarge MJ, and Kline RH (1999) CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter. J Med Chem 42:3502-3509.
29. Nichols DE (1994) Medicinal chemistry and structure-activity relationships, in Amphetamine and Its Analogs (Cho AK and Segal DS eds) pp 3-41, Academic Press, San Diego.
30. Owens MJ, Morgan WN, Plott SJ, and Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322.
31. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, and Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
32. Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, and van Den BW (2002) Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study-preliminary report. Psychopharmacology 159:335-340.
33. Rodriguez GJ, Roman DL, White KJ, Nichols DE, and Barker EL (2003) Distinct recognition of substrates by the human and Drosophila serotonin transporters. J Pharmacol Exp Ther 306:338-346.
34. Rudnick G and Clark J (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144:249-263.
35. Scheffel U, Lever JR, Abraham P, Parham KR, Mathews WB, Kopajtic T, Carroll FI, and Kuhar MJ (1997) N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter. Synapse 25:345-349.
36. Schloss P and Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115-121.
37. Usdin TB, Mezey E, Chen C, Brownstein MJ, and Hoffman BJ (1991) Cloning of the cocaine-sensitive bovine dopamine transporter. Proc Natl Acad Sci USA 88: 11168-11171.
38. Uhl GR, Hall FS, and Sora I (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7:21-26.
39. Wall SC, Gu H, and Rudnick G (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharm 47:544-550.
40. Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, and Neve KA (1998) CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. J Med Chem 41:4385-4399.